Overview

A Study to Evaluate the Effect of Co-administration on the Pharmacokinetics of SPR720, Azithromycin, and Ethambutol in Healthy Participants

Status:
Completed

Trial end date:
2024-02-04

Target enrollment:

Participant gender:

Summary

The primary purpose of this study is to evaluate the pharmacokinetics (PK) of SPR720, azithromycin, and ethambutol, administered separately and co-administered, in healthy adult participants.

Phase:

Phase 1

Details

Lead Sponsor:

Spero Therapeutics

Treatments:

Azithromycin
Ethambutol